Protalex, Inc. (PRTX)
Stock Price: $0.0076 USD
0.0000 (0.00%)
Updated Jan 7, 2021 9:30 AM EST - Market closed
Market Cap | 473 |
Revenue (ttm) | n/a |
Net Income (ttm) | -4.65M |
Shares Out | 47.33M |
EPS (ttm) | -0.12 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 7 |
Last Price | $0.0076 |
Previous Close | $0.0000 |
Change ($) | 0.0000 |
Change (%) | 0.00% |
Day's Open | - |
Day's Range | 0.0003 - 0.0076 |
Day's Volume | 0 |
52-Week Range | 0.0001 - 0.0100 |
News
There are no news available yet.
About PRTX
Protalex focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of pati... [Read more...]
Industry Drug Manufacturers - Other | IPO Date Jan 11, 2000 |
Stock Exchange OTCMKTS | Ticker Symbol PRTX |